CoinScoopU.S. Stocks Open: uniQure Drops 39%, Summit Therapeutics Rises 19.2%
At the market open, the Dow fell 0.1%, while the S&P 500 and Nasdaq rose 0.13% and 0.3%, respectively. Biopharmaceutical firm uniQure declined 39% after 48-month data for its Huntington's disease gene therapy failed to reach statistical significance. Summit Therapeutics climbed 19.2% following news of a potential $2 billion investment from AstraZeneca for cancer drug development.
Summaries are written by AI from the original article. Not investment advice.